{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:34:45Z","timestamp":1772829285193,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T00:00:00Z","timestamp":1512518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/npp.2017.298","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T08:00:57Z","timestamp":1516780857000},"page":"1247-1256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial"],"prefix":"10.1038","volume":"43","author":[{"given":"Joseph P","family":"Schacht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin E","family":"Voronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick K","family":"Randall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond F","family":"Anton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"BFnpp2017298_CR1","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/npp.2010.68","volume":"35","author":"E Aarts","year":"2010","unstructured":"Aarts E, Roelofs A, Franke B, Rijpkema M, Fernandez G, Helmich RC et al (2010). Striatal dopamine mediates the interface between motivational and cognitive control in humans: evidence from genetic imaging. Neuropsychopharmacology 35: 1943\u20131951.","journal-title":"Neuropsychopharmacology"},{"issue":"7 Suppl","key":"BFnpp2017298_CR2","doi-asserted-by":"publisher","first-page":"3A","DOI":"10.1111\/j.1530-0277.1996.tb01183.x","volume":"20","author":"RF Anton","year":"1996","unstructured":"Anton RF (1996). New methodologies for pharmacological treatment trials for alcohol dependence. Alcohol Clin Exp Res 20 (7 Suppl): 3A\u20139A.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp2017298_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/jcp.0b013e3181602fd4","volume":"28","author":"RF Anton","year":"2008","unstructured":"Anton RF, Kranzler H, Breder C, Marcus RN, Carson WH, Han J (2008). A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol 28: 5\u201312.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp2017298_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archpsyc.1996.01830030047008","volume":"53","author":"RF Anton","year":"1996","unstructured":"Anton RF, Moak DH, Latham PK (1996). The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 53: 225\u2013231.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2017298_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/acer.13417","volume":"41","author":"RF Anton","year":"2017","unstructured":"Anton RF, Schacht JP, Voronin KE, Randall PK (2017). Aripiprazole suppression of drinking in a clinical laboratory paradigm: influence of impulsivity and self-control. Alcohol Clin Exp Res 41: 1370\u20131380.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp2017298_CR6","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/j.1530-0277.2012.01807.x","volume":"36","author":"RF Anton","year":"2012","unstructured":"Anton RF, Voronin KK, Randall PK, Myrick H, Tiffany A (2012). Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. Alcohol Clin Exp Res 36: 2000\u20132007.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp2017298_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1046\/j.1471-4159.1995.65031157.x","volume":"65","author":"V Asghari","year":"1995","unstructured":"Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH (1995). Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65: 1157\u20131165.","journal-title":"J Neurochem"},{"key":"BFnpp2017298_CR8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/npp.2015.5","volume":"40","author":"G Blasi","year":"2015","unstructured":"Blasi G, Selvaggi P, Fazio L, Antonucci LA, Taurisano P, Masellis R et al (2015). Variation in dopamine D2 and serotonin 5-HT2A receptor genes is associated with working memory processing and response to treatment with antipsychotics. Neuropsychopharmacology 40: 1600\u20131608.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/syn.10226","volume":"49","author":"I Boileau","year":"2003","unstructured":"Boileau I, Assaad J-M, Pihl RO, Benkelfat C, Leyton M, Diksic M et al (2003). Alcohol promotes dopamine release in the human nucleus accumbens. Synapse (New York, NY) 49: 226\u2013231.","journal-title":"Synapse (New York, NY)"},{"key":"BFnpp2017298_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/archpsyc.63.7.808","volume":"63","author":"AL Brody","year":"2006","unstructured":"Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S et al (2006). Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate\/nucleus accumbens. Arch Gen Psychiatry 63: 808\u2013816.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2017298_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s004390050166","volume":"98","author":"FM Chang","year":"1996","unstructured":"Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK (1996). The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet 98: 91\u2013101.","journal-title":"Hum Genet"},{"key":"BFnpp2017298_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/425589","volume":"75","author":"J Chen","year":"2004","unstructured":"Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S et al (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75: 807\u2013821.","journal-title":"Am J Hum Genet"},{"key":"BFnpp2017298_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ahg.12046","volume":"78","author":"TK Clarke","year":"2014","unstructured":"Clarke TK, Weiss AR, Ferarro TN, Kampman KM, Dackis CA, Pettinati HM et al (2014). The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann Hum Genet 78: 33\u201339.","journal-title":"Ann Hum Genet"},{"key":"BFnpp2017298_CR14","volume-title":"Statistical Power Analysis for the Behavioural Sciences","author":"J Cohen","year":"1969","unstructured":"Cohen J (1969) Statistical Power Analysis for the Behavioural Sciences. Academic Press: New York."},{"key":"BFnpp2017298_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1073\/pnas.0805517106","volume":"106","author":"J-C Dreher","year":"2009","unstructured":"Dreher J-C, Kohn P, Kolachana B, Weinberger DR, Berman KF (2009). Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA 106: 617\u2013622.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2017298_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/mp.2013.126","volume":"19","author":"SV Faraone","year":"2014","unstructured":"Faraone SV, Spencer TJ, Madras BK, Zhang-James Y, Biederman J (2014). Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis. Mol Psychiatry 19: 880\u2013889.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2017298_CR17","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/j.1369-1600.2011.00328.x","volume":"17","author":"FM Filbey","year":"2011","unstructured":"Filbey FM, Claus ED, Morgan M, Forester GR, Hutchison K (2011). Dopaminergic genes modulate response inhibition in alcohol abusing adults. Addict Biol 17: 1046\u20131056.","journal-title":"Addict Biol"},{"key":"BFnpp2017298_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1530-0277.2008.00692.x","volume":"32","author":"FM Filbey","year":"2008","unstructured":"Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE (2008). Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res 32: 1113\u20131123.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp2017298_CR19","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition","author":"MB First","year":"2002","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. Biometrics Research, New York State Psychiatric Institute: New York."},{"key":"BFnpp2017298_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/sj.mp.4002086","volume":"14","author":"EE Forbes","year":"2009","unstructured":"Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR (2009). Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14: 60\u201370.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2017298_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/npp.2008.124","volume":"34","author":"TR Franklin","year":"2009","unstructured":"Franklin TR, Lohoff FW, Wang Z, Sciortino N, Harper D, Li Y et al (2009). DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology 34: 717\u2013728.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1369-1600.2010.00277.x","volume":"16","author":"TR Franklin","year":"2011","unstructured":"Franklin TR, Wang Z, Li Y, Suh JJ, Goldman M, Lohoff FW et al (2011). Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. Addict Biol 16: 308\u2013322.","journal-title":"Addict Biol"},{"key":"BFnpp2017298_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/sj.tpj.6500026","volume":"1","author":"S Fuke","year":"2001","unstructured":"Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S (2001). The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenom J 1: 152\u2013156.","journal-title":"Pharmacogenom J"},{"key":"BFnpp2017298_CR24","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1111\/j.1467-7687.2006.00579.x","volume":"10","author":"A Galvan","year":"2007","unstructured":"Galvan A, Hare T, Voss H, Glover G, Casey BJ (2007). Risk-taking and the adolescent brain: who is at risk? Dev Sci 10: F8\u2013F14.","journal-title":"Dev Sci"},{"key":"BFnpp2017298_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0893-133X(99)00099-8","volume":"22","author":"A Heinz","year":"2000","unstructured":"Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG et al (2000). Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22: 133\u2013139.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1037\/0278-6133.21.2.139","volume":"21","author":"KE Hutchison","year":"2002","unstructured":"Hutchison KE, McGeary J, Smolen A, Bryan A, Swift RM (2002). The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association 21: 139\u2013146.","journal-title":"Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association"},{"key":"BFnpp2017298_CR27","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/sj.npp.1300917","volume":"31","author":"KE Hutchison","year":"2006","unstructured":"Hutchison KE, Ray L, Sandman E, Rutter M-C, Peters A, Davidson D et al (2006). The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology 31: 1310\u20131317.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR28","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/sj.npp.1300264","volume":"28","author":"KE Hutchison","year":"2003","unstructured":"Hutchison KE, Wooden A, Swift RM, Smolen A, McGeary J, Adler L et al (2003). Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology 28: 1882\u20131888.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR29","doi-asserted-by":"publisher","first-page":"e46488","DOI":"10.1371\/journal.pone.0046488","volume":"7","author":"H Ito","year":"2012","unstructured":"Ito H, Takano H, Arakawa R, Takahashi H, Kodaka F, Takahata K et al (2012). Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[beta-11C]DOPA. PLoS ONE 7: e46488.","journal-title":"PLoS ONE"},{"key":"BFnpp2017298_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0006-3223(99)00101-8","volume":"46","author":"AM Kang","year":"1999","unstructured":"Kang AM, Palmatier MA, Kidd KK (1999). Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 46: 151\u2013160.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2017298_CR31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/npp.2014.240","volume":"40","author":"AM Kasparbauer","year":"2015","unstructured":"Kasparbauer AM, Rujescu D, Riedel M, Pogarell O, Costa A, Meindl T et al (2015). Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability. Neuropsychopharmacology 40: 736\u2013745.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR32","doi-asserted-by":"crossref","unstructured":"Khanna P, Suo T, Komossa K, Ma H, Rummel-Kluge C, El-Sayeh HG et al (2014). Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev CD006569.","DOI":"10.1002\/14651858.CD006569.pub5"},{"key":"BFnpp2017298_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ajmg.b.30586","volume":"147B","author":"JS Kooij","year":"2008","unstructured":"Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK et al (2008). Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). Am J Med Genet B Neuropsychiatr Genet 147B: 201\u2013208.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFnpp2017298_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1530-0277.2007.00608.x","volume":"32","author":"HR Kranzler","year":"2008","unstructured":"Kranzler HR, Covault J, Pierucci-Lagha A, Chan G, Douglas K, Arias AJ et al (2008). Effects of aripiprazole on subjective and physiological responses to alcohol. Alcohol Clin Exp Res 32: 573\u2013579.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp2017298_CR35","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1162\/jocn_a_00946","volume":"28","author":"HJ MacDonald","year":"2016","unstructured":"MacDonald HJ, Stinear CM, Ren A, Coxon JP, Kao J, Macdonald L et al (2016). Dopamine gene profiling to predict impulse control and effects of dopamine agonist ropinirole. J Cogn Neurosci 28: 909\u2013919.","journal-title":"J Cogn Neurosci"},{"key":"BFnpp2017298_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0091270003261901","volume":"44","author":"S Mallikaarjun","year":"2004","unstructured":"Mallikaarjun S, Salazar DE, Bramer SL (2004). Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers. J Clin Pharmacol 44: 179\u2013187.","journal-title":"J Clin Pharmacol"},{"key":"BFnpp2017298_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.biopsych.2005.04.044","volume":"58","author":"D Martinez","year":"2005","unstructured":"Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A et al (2005). Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 58: 779\u2013786.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2017298_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pbb.2009.03.010","volume":"93","author":"J McGeary","year":"2009","unstructured":"McGeary J (2009). The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review. Pharmacol Biochem Behav 93: 222\u2013229.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2017298_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/JCP.0b013e3181e75cff","volume":"30","author":"H Myrick","year":"2010","unstructured":"Myrick H, Li X, Randall PK, Henderson S, Voronin K, Anton RF (2010). The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol 30: 365\u2013372.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp2017298_CR40","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/npp.2011.82","volume":"36","author":"YS Nikolova","year":"2011","unstructured":"Nikolova YS, Ferrell RE, Manuck SB, Hariri AR (2011). Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology 36: 1940\u20131947.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR41","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/npp.2013.91","volume":"38","author":"BG Oberlin","year":"2013","unstructured":"Oberlin BG, Dzemidzic M, Tran SM, Soeurt CM, Albrecht DS, Yoder KK et al (2013). Beer flavor provokes striatal dopamine release in male drinkers: mediation by family history of alcoholism. Neuropsychopharmacology 38: 1617\u20131624.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0006-3223(99)00098-0","volume":"46","author":"MA Palmatier","year":"1999","unstructured":"Palmatier MA, Kang AM, Kidd KK (1999). Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46: 557\u2013567.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2017298_CR43","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton JH, Stanford MS, Barratt ES (1995). Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51: 768\u2013774.","journal-title":"J Clin Psychol"},{"key":"BFnpp2017298_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/00952990.2017.1312423","volume":"43","author":"LA Ray","year":"2017","unstructured":"Ray LA, Bujarski S, Yardley MM, Roche DJO, Hartwell EE (2017). Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter? Am J Drug Alcohol Abuse 43: 703\u2013710.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BFnpp2017298_CR45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/tpj.2016.43","volume":"16","author":"JP Schacht","year":"2016","unstructured":"Schacht JP (2016). COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review. Pharmacogenomics J 16: 430\u2013438.","journal-title":"Pharmacogenomics J"},{"key":"BFnpp2017298_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuroimage.2011.02.004","volume":"56","author":"JP Schacht","year":"2011","unstructured":"Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H (2011). Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. NeuroImage 56: 61\u201368.","journal-title":"NeuroImage"},{"key":"BFnpp2017298_CR47","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/npp.2012.195","volume":"38","author":"JP Schacht","year":"2013","unstructured":"Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S et al (2013). Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology 38: 414\u2013422.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR48","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1038\/npp.2017.185","volume":"42","author":"JP Schacht","year":"2017","unstructured":"Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H et al (2017). Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status. Neuropsychopharmacology 42: 2654.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/archgenpsychiatry.2011.1335","volume":"69","author":"AF Schellekens","year":"2012","unstructured":"Schellekens AF, Franke B, Ellenbroek B, Cools A, de Jong CA, Buitelaar JK et al (2012). Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes. Arch Gen Psychiatry 69: 339\u2013348.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2017298_CR50","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","volume":"28","author":"DA Shapiro","year":"2003","unstructured":"Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR et al (2003). Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28: 1400\u20131411.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR51","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ajmg.b.31084","volume":"153B","author":"J Simpson","year":"2010","unstructured":"Simpson J, Vetuz G, Wilson M, Brookes KJ, Kent L (2010). The DRD4 receptor Exon 3 VNTR and 5' SNP variants and mRNA expression in human post-mortem brain tissue. Am J Med Genet B Neuropsychiatr Genet 153B: 1228\u20131233.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFnpp2017298_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1037\/0021-843X.91.3.199","volume":"91","author":"HA Skinner","year":"1982","unstructured":"Skinner HA, Allen BA (1982). Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91: 199\u2013209.","journal-title":"J Abnorm Psychol"},{"issue":"Suppl 1","key":"BFnpp2017298_CR53","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"SM Smith","year":"2004","unstructured":"Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H et al (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23 (Suppl 1): S208\u2013S219.","journal-title":"NeuroImage"},{"key":"BFnpp2017298_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring Alcohol Consumption: Psychosocial and Biochemical Methods","author":"LC Sobell","year":"1992","unstructured":"Sobell LC, Sobell MB (1992) Timeline follow-back: a technique for assessing self-reported alcohol consumption In: Allen JP, Litten RZ (eds) Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Humana Press: Totowa, NJ. pp 41\u201372."},{"key":"BFnpp2017298_CR55","doi-asserted-by":"publisher","first-page":"10093","DOI":"10.1523\/JNEUROSCI.1506-12.2012","volume":"32","author":"E Stice","year":"2012","unstructured":"Stice E, Yokum S, Burger K, Epstein L, Smolen A (2012). Multilocus genetic composite reflecting dopamine signaling capacity predicts reward circuitry responsivity. J Neurosci 32: 10093\u201310100.","journal-title":"J Neurosci"},{"key":"BFnpp2017298_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.15288\/jsas.1994.s12.70","volume":"12","author":"RL Stout","year":"1994","unstructured":"Stout RL, Wirtz PW, Carbonari JP, Del Boca FK (1994). Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl 12: 70\u201375.","journal-title":"J Stud Alcohol Suppl"},{"key":"BFnpp2017298_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1037\/0893-164X.18.2.148","volume":"18","author":"WG Stritzke","year":"2004","unstructured":"Stritzke WG, Breiner MJ, Curtin JJ, Lang AR (2004). Assessment of substance cue reactivity: advances in reliability, specificity, and validity. Psychol Addict Behav 18: 148\u2013159.","journal-title":"Psychol Addict Behav"},{"key":"BFnpp2017298_CR58","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","volume":"84","author":"JT Sullivan","year":"1989","unstructured":"Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989). Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84: 1353\u20131357.","journal-title":"Br J Addict"},{"key":"BFnpp2017298_CR59","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00213-011-2340-2","volume":"218","author":"M van Holstein","year":"2011","unstructured":"van Holstein M, Aarts E, van der Schaaf ME, Geurts DE, Verkes RJ, Franke B et al (2011). Human cognitive flexibility depends on dopamine D2 receptor signaling. Psychopharmacology (Berl) 218: 567\u2013578.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2017298_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/187152710790966731","volume":"9","author":"DE Vergne","year":"2010","unstructured":"Vergne DE, Anton RF (2010). Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence. CNS Neurol Disord Drug Targets 9: 50\u201354.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"BFnpp2017298_CR61","doi-asserted-by":"publisher","first-page":"12700","DOI":"10.1523\/JNEUROSCI.3371-07.2007","volume":"27","author":"ND Volkow","year":"2007","unstructured":"Volkow ND, Wang G-J, Telang F, Fowler JS, Logan J, Jayne M et al (2007). Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 27: 12700\u201312706.","journal-title":"J Neurosci"},{"key":"BFnpp2017298_CR62","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/j.1530-0277.2008.00783.x","volume":"32","author":"K Voronin","year":"2008","unstructured":"Voronin K, Randall P, Myrick H, Anton R (2008). Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm\u2014possible influence of self-control. Alcohol Clin Exp Res 32: 1954\u20131961.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp2017298_CR63","volume-title":"Human Metabolism of Alcohol (Vol. 1): Pharmacokinetics, Medicolegal Aspects, and General Interest","author":"PE Watson","year":"1989","unstructured":"Watson PE (1989) Total body water and blood alcohol levels: Updating the fundamentals In: Crow KE, Batt RD (eds) Human Metabolism of Alcohol (Vol. 1): Pharmacokinetics, Medicolegal Aspects, and General Interest. CRC Press: Boca Raton."},{"key":"BFnpp2017298_CR64","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/acer.12257","volume":"38","author":"CJ Wong","year":"2014","unstructured":"Wong CJ, Witcher J, Mallinckrodt C, Dean RA, Anton RF, Chen Y et al (2014). A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence. Alcohol Clin Exp Res 38: 511\u2013520.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp2017298_CR65","doi-asserted-by":"publisher","first-page":"8125","DOI":"10.1073\/pnas.0702029104","volume":"104","author":"J Yacubian","year":"2007","unstructured":"Yacubian J, Sommer T, Schroeder K, Glascher J, Kalisch R, Leuenberger B et al (2007). Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci USA 104: 8125\u20138130.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2017298_CR66","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.drugalcdep.2016.01.001","volume":"160","author":"KK Yoder","year":"2016","unstructured":"Yoder KK, Albrecht DS, Dzemidzic M, Normandin MD, Federici LM, Graves T et al (2016). Differences in IV alcohol-induced dopamine release in the ventral striatum of social drinkers and nontreatment-seeking alcoholics. Drug Alcohol Depend 160: 163\u2013169.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2017298_CR67","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0893-133X(02)00304-4","volume":"27","author":"F Yokoi","year":"2002","unstructured":"Yokoi F, Grunder G, Biziere K, Stephane M, Dogan AS, Dannals RF et al (2002). Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology 27: 248\u2013259.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017298_CR68","doi-asserted-by":"publisher","first-page":"20552","DOI":"10.1073\/pnas.0707106104","volume":"104","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R et al (2007). Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104: 20552\u201320557.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2017298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017298","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/npp.2017.298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T18:18:07Z","timestamp":1719771487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2017298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,6]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["BFnpp2017298"],"URL":"https:\/\/doi.org\/10.1038\/npp.2017.298","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,6]]},"assertion":[{"value":"9 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}